Elan Corp., plc
Neuroscience-based biotech settles legal action with former employee
Published in Pharma Investments, Ventures and Law Weekly, July 17th, 2005
The action related to the agreement for the exercise of share options granted to Geaney during his period as an employee of the company.
The settlement, with no admission of liability on the part of the company, was for a sum of EUR 3.5 million plus an agreed sum of costs.
Elan Corp., plc, is a neuroscience-based biotechnology company. Elan shares trade on the New York, London, and Dublin stock exchanges.
This article was prepared by Pharma Investments, Ventures & Law Weekly editors from staff and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Arrowhead Research Corporation
Nanotech company revises commercialization strategy - Arrowhead Research Corporation
Nanotechnology firm completes warrant redemption - BioVeris Corporation
Diagnostics company reports loss of $0.27 per share - Biophan Technologies, Inc.
Patent allowed for solution to enhance image quality of MRI - CV Therapeutics, Inc.
Biopharmaceutical firm reports option grants - Caraco Pharmaceutical Laboratories, Ltd.
Pharmaceutical company reports 27% increase in sales - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
